Cargando…
Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro Results
MB-102 is a novel fluorescent tracer agent that is exclusively removed from the body by glomerular filtration. This agent can be detected transdermally to provide a real-time measurement of glomerular filtration rate at the point-of-care and is currently in clinical studies for such. MB-102 clearanc...
Autores principales: | Jang, Soo M., Shieh, Jeng-Jong, Riley, Ivan R., Dorshow, Richard B., Mueller, Bruce A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298171/ https://www.ncbi.nlm.nih.gov/pubmed/37071749 http://dx.doi.org/10.1097/MAT.0000000000001943 |
Ejemplares similares
-
Transdermal Detection of MB-102 and Correlation to Meropenem Pharmacokinetics During Continuous Renal Replacement Therapy: In Vivo Results
por: Dorshow, Richard B., et al.
Publicado: (2023) -
An Innovative Approach to Minimizing Downtime in Continuous Kidney Replacement Therapy
por: Treu, Denny, et al.
Publicado: (2023) -
Comparative Effectiveness of Dialyzers: A Longitudinal, Propensity Score-Matched Study of Incident Hemodialysis Patients
por: Sibbel, Scott, et al.
Publicado: (2016) -
Initial Clinical Experience with a Symmetric Tip Tunneled Hemodialysis Catheter Without Side Holes
por: Tal, Michael G., et al.
Publicado: (2021) -
Real-World Performance of High-Flux Dialyzers in Patients With Hypoalbuminemia
por: Zhou, Meijiao, et al.
Publicado: (2021)